Geoffrey Seiler
Bullmarket.com
J. Royden Ward
Cabot Benjamin Graham Value Letter
Jack Adamo
Insiders Plus
Chuck Carlson
The DRIP Investor

Reaves Utility: Favorite for uncertain times


Bookmark and Share
by Amy Calistri, editor The Daily Paycheck

amy calistriI don't believe investing strategies have to be complex to outperform the market. And I don't believe anyone should have to lose sleep worrying about their portfolio.

Our portfolio does particularly well in in uncertain times because all of my holdings pay dividends. Dividend, like shock absorbers, cushion my total returns when market prices hit a pothole. And one standout for dividend investors is Reaves Utility Fund (UTG).

Reaves Utility is in my "Steady Income Generators" portfolio. This closed-end fund has a lovely portfolio of solid utility and telecom stocks -- good defensive securities for bumpy times.

The market may have dropped double-digits last summer. But shares of this closed-end fund held up particularly well. UTG lost about 2.3% in price and only 0.8% in total returns. Here, UTG's defensive utility and telecom portfolio get the credit.

Utilities and telecom services are necessities. And the companies that provide these services are generally known for having good cash flow and stable dividends. With roughly 70 holdings, UTG owns a good cross-section of these sectors.

Telecoms make up roughly 24% of UTG's portfolio and include stalwarts like AT&T and Verizon, along with the more speculative Windstream.

Roughly two-thirds of its portfolio is invested in traditional utility companies such as Southern and South Jersey Industries. But it also has some holdings hailing from the oil and gas sector such as Occidental Petroleum and Seadrill Ltd.

UTG pays a monthly dividend of $0.125 per share. The fund also distributed a special dividend of $0.332 per share at the end of last year. Just counting its normal distributions, UTG has a current yield of 5.8%.

It has been a little more than a year since UTG's last dividend increase. Based on the health of the companies in its portfolio, I think there is a good chance we could see another dividend increase from UTG in the near future. 

Action to Take --> UTG is one of the most diversified utility funds around. When asked for a list his favorite funds, PIMCO founder and bond expert Bill Gross almost always names Reaves -- choosing it over the funds his own company manages.

It is one of may favorites as well. I think its defensive portfolio is especially well-suited for our current market conditions.

Learn more about this financial newsletter at Amy Calistri's The Daily Paycheck.

Related articles:


Advertisement
Banner
News Flash

Charged up over Visa
by Leo Fasciocco, editor Ticker Tape Digest

With solid earnings growth coming for the next several quarters, we see Visa Inc. (V) as a good stock to accumulate in anticipation of a breakout. It is currently an institutional favorite based on its steady earnings growth record.


Read more...

 

William Blair: Small cap risk & reward
by Walter Frank, editor MoneyLetter

With 44% of net assets in micro-cap and another 44% in small cap fare, William Blair Small Cap Growth (WBSNX) truly lands at the tinest end of the small cap fund spectrum. That in itself courts more risk than the typical small-cap growth fund.


Read more...


   

Air and auto parts: Rebound buys
by Richard Moroney, editor Upside Stocks

Here, we profile two are attractive rebound plays -- Penske Automotive (PAG) and Triumph (TGI). Both seem capable of attracting investors’ attention and rallying in the year ahead.


Read more...

 

Fidelity: International buys
by Jim Lowell, editor Fidelity Investor

I continue to think the best way to pursue foreign stock opportunities is through managers with longstanding expertise in the foreign stock arena. Here's a look at four of our buy-rated international funds.


Read more...

 

Parexel: One-stop shop in clinical trials
by Mike Cintolo, editor Cabot Top Ten Trader

Parexel International (PRXL) has a great niche in the pharmaceutical industry. Its main service is outsourcing medical research and clinical trials of candidate drugs. Its one-stop-shopping approach to drug development and trials lets Parexel take over the work of an entire division, saving clients enormous amounts of expense.


Read more...

 

Cisco: 'Plenty of room for growth'
by Brian Hicks, editor The Wealth Advisory

CEO John Chambers is making us look good; it is now nine consecutive quarters that Cisco Systems (CSCO) has beaten analysts' earnings estimates.


Read more...

 

Strong growth at value prices
by Stephen Quickel, editor US Investment Report

In selecting new stocks for the Recommended List we aim for leaders in top growth sectors that we think can generate price gains of at least 20%. Here's a look at 5 'buys'.


Read more...

 

Military matters: Top picks in defense
by Jim Powell, editor Global Changes & Opportunities

I continue to recommend leading U.S. defense stocks that have been greatly oversold by investors who are worried about deep cutbacks. Although some expensive “big iron” contracts will be cancelled, I believe many new high tech orders will more than make up for their loss.


Read more...

 

StoneMor: Timely buy in untimely market
by Steve Mauzy, contributing editor Daily Profit

Thanks to baby boomers hitting their golden years en masse, annual deaths in the United States are expected to rise to 3.2 million in 2030 from 2.6 million in 2010. For income-and-yield investors, there's really only one choice in the cemetery sector -- StoneMor Partners (STON), which yields over 9%.


Read more...

 

Norfolk Southern: Rail for reinvesting
by Vita Nelson, editor Direct Investing

Choosing to own companies that grow their earnings and dividends consistently over time means taking advantage of compounding both within the company and within the stock market, no matter what the latest noise may be.


Read more...

 



Banner



Close
Select Offer: Schwab Options Market Commentary